Mirtazapine
Product Images NDC 67046-319

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 67046-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

M15 (Mirtazapine 15mg 319)

M15 (Mirtazapine 15mg 319)
This is a description of a medication named Mirtazapine. The medication is provided in the form of a tablet and comes in a package of 30. It is produced by Aurobindo Pharma. The tablets contain 15mg of Mirtazapine. The medication is typically prescribed by a doctor and the appropriate dosage should be advised by them. The medication should be kept in a light-resistant container and stored at a temperature between 25°C to 30°C. The medication has been packaged by the Contract Pharmacy Services and the NDC code is 67046-319-30.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.